Thiamine-dependent regulation of mammalian brain pyridoxal kinase in vitro and in vivo
Where the research is specific, we say so and where it is not, we say that too
Brand prices are list prices without insurance.* ## What Brand Retatrutide Will Likely Cost (Post-Approval) Based on [tirzepatide](/guides/tirzepatide-cost-price-guide-2026) (Zepbound at $1,059/month) and semaglutide (Wegovy at $1,349/month) pricing: | Scenario | Expected Monthly Cost | |----------|---------------------| | List price (no insurance) | $1,100-1,400 | | With commercial insurance | $25-500 (highly variable) | | With manufacturer savings card | Potentially $25-150 | The math is clear: [compounded retatrutide](/products/retatrutide-001) at $300-500/month is substantially cheaper than what the brand will cost
[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Nicoletti V.G., Santoro A.M., Grasso G., Vagliasindi L.I., Giuffrida M.L., Cuppari C., Purrello V.S., Stella A.M.G., Rizzarelli E
Think of it less like a peak and more like a window of opportunity
Differential effect of quercetin on cisplatin-induced toxicity in kidney and tumor tissues